Printer Friendly

VITAL HEART SYSTEMS, INC. ANNOUNCES APPOINTMENT OF NEW PRESIDENT & CHIEF EXECUTIVE OFFICER AND COMPLETION OF THE INITIAL PHASE OF FINANCING

 MINNEAPOLIS/BOSTON, May 18 /PRNewswire/ -- Vital Heart Systems, Inc. (NASDAQ: VHRT), announced today the appointment of G. Robert Tatum III as president and chief executive officer. Tatum is a partner of DaVinci Scientific Corporation along with H. Stephen Cookston, executive vice president, and David L. Printy, chairman of the board with Vital Heart Systems. Tatum brings over 26 years of experience in sales, customer service, operations, product development and medical technology. He previously held senior positions with Vitatron (sold to Medtronics), General Electric, General Dynamics, Electronic Data Systems and Control Data.
 "The appointment of a seasoned executive to the position of president and CEO is a continuation of the company's original long-term plan to reorganize Vital Heart Systems," said David L. Printy, chairman of the board.
 Vital Heart Systems, Inc. also announced that it has completed the initial phase of its previously announced $1.5 million private equity financing. This initial phase totals $550,000 including $135,000 from one of the company's primary suppliers subject to the satisfaction of certain conditions. DaVinci Scientific, Inc. has informed the company that it will invest an additional $400,000. Each unit of the private equity financing consists of restricted common stock and Class C Warrants. Provided certain conditions are met, DaVinci Scientific has committed to extend a $1 million line of credit to the company in the form of a convertible debenture. The company is working to complete the goal of $1.5 million in private equity financing.
 "I am very excited about my expanded role as president and CEO. DaVinci Scientific is pleased to play a significant role in the financing, marketing and ultimate success of this extremely important new technology to aid physicians in the early detection of coronary artery disease," said Robert Tatum, president and CEO.
 Vital Heart Systems also announced revenues of $5,412 and a net loss of $.04 per share for the first quarter ended March 31, 1993. This compares to revenues of $81,847 and a net loss of $.02 per share for the first quarter of 1992. During the first quarter of 1993, the company placed seven variance cardiographs(TM) under evaluation agreements.
 FINANCIAL SUMMARY
 Three Months Ended Three Months Ended
 3/31/93 3/31/92
 Revenues $5,412 $81,847
 Cost of sales
 & expenses 825,718 504,072
 Operating income (loss) (820,306) (422,225)
 Interest and misc.
 expenses (10,115) (12,233)
 Net income (loss) $(830,421) $(434,458)
 Net income (loss)
 per common share $(.04) $(.02)
 Weighted average shares 22,310,148 19,014,187
 "Our new Digital Equipment Corporation (DEC) based product is nearing completion. Vital Heart Systems is shifting its focus from research & development toward marketing and revenue recognition with the planned introduction of its new product in July 1993. In addition to revenues, cost containment continues to be an important focus of senior management," commented Tatum.
 Vital Heart Systems, Inc. with headquarters in Beverly, Mass. develops and markets the Variance Cardiograph(TM), a non-invasive, stress-free, diagnostic instrument to aid physicians in the diagnosis of coronary artery disease. The stock of Vital Heart Systems, Inc. is traded on the over-the-counter market under the NASDAQ symbol VHRT.
 -0- 5/18/93
 /CONTACT: Deborah Meacock, director, investor relations of Vital Heart Systems, 612-341-4489/
 (VHRT)


CO: Vital Heart Systems, Inc. ST: Minnesota, Massachusetts IN: MTC SU: FIN

DB -- MN010 -- 9894 05/18/93 15:25 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 18, 1993
Words:565
Previous Article:FEDERAL JUDGE FINDS THAT KHAN LIED UNDER OATH; TRADED ON INSIDER INFORMATION; FAILED TO DISCLOSE MATERIAL INFORMATION IN FILINGS
Next Article:/Repeating from yesterday for points missed./
Topics:


Related Articles
REPEATING FOR POINTS MISSED VITAL HEART SYSTEMS APPOINTS VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
VITAL HEART SYSTEMS APPOINTS SENIOR EXECUTIVES TO MANAGE AND DIRECT SALES
VITAL HEART SYSTEMS, INC. ANNOUNCES FINANCING AND FOURTH QUARTER RESULTS
VITAL HEART SYSTEMS, INC. ANNOUNCES VERY SUCCESSFUL LAUNCH OF VITAL HEART CHECKPOINT CENTERS
VITAL HEART SYSTEMS' RECENTLY ELECTED PRESIDENT & CEO AND EXECUTIVE VICE PRESIDENT ARE ELECTED TO BOARD OF DIRECTORS
VITAL HEART SYSTEMS ANNOUNCES LICENSING AGREEMENT
CONCEPTUS MOVES FORWARD WITH FALLOPOSCOPY STUDY, COMPLETES SECOND ROUND OF FINANCING
PERCLOSE APPOINTS CHIEF FINANCIAL OFFICER
SINGER JOINS HEARTPORT AS SENIOR V.P., FINANCE AND CFO
ATTENTION BUSINESS/FINANCIAL EDITORS:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters